Darrell S. Pardi

16.5k total citations · 2 hit papers
309 papers, 10.8k citations indexed

About

Darrell S. Pardi is a scholar working on Epidemiology, Infectious Diseases and Genetics. According to data from OpenAlex, Darrell S. Pardi has authored 309 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 203 papers in Epidemiology, 121 papers in Infectious Diseases and 110 papers in Genetics. Recurrent topics in Darrell S. Pardi's work include Microscopic Colitis (182 papers), Clostridium difficile and Clostridium perfringens research (116 papers) and Inflammatory Bowel Disease (107 papers). Darrell S. Pardi is often cited by papers focused on Microscopic Colitis (182 papers), Clostridium difficile and Clostridium perfringens research (116 papers) and Inflammatory Bowel Disease (107 papers). Darrell S. Pardi collaborates with scholars based in United States, United Kingdom and Canada. Darrell S. Pardi's co-authors include Sahil Khanna, Edward V. Loftus, William J. Sandborn, William J. Tremaine, Siddharth Singh, Patricia P. Kammer, Alan R. Zinsmeister, Raseen Tariq, Thomas C. Smyrk and William S. Harmsen and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Darrell S. Pardi

298 papers receiving 10.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study

2011 488 citations Sahil Khanna, Darrell S. Pardi et al. The American Journal of Gastroenterology profile →
VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection

2023 120 citations Thomas Louie, Sahil Khanna et al. profile →

Peers

Countries citing papers authored by Darrell S. Pardi

Since Specialization

Citations

This map shows the geographic impact of Darrell S. Pardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darrell S. Pardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darrell S. Pardi more than expected).

Fields of papers citing papers by Darrell S. Pardi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darrell S. Pardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darrell S. Pardi. The network helps show where Darrell S. Pardi may publish in the future.

Co-authorship network of co-authors of Darrell S. Pardi

This figure shows the co-authorship network connecting the top 25 collaborators of Darrell S. Pardi. A scholar is included among the top collaborators of Darrell S. Pardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darrell S. Pardi. Darrell S. Pardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparability of Gastrointestinal Microbiome and Bile Acid Profiles in Patients With First or Multiply Recurrent Clostridioides difficile Infection 2025 ·The Journal of Infectious Diseases ·Jessica A. Bryant, Timothy J. Straub, Darrell S. Pardi, (unknown), Colleen Kelly, Meghan Chafee, Stuart H. Cohen, Sahil Khanna, Charles S. Berenson, Jennifer R. Wortman, Matthew Sims, Christopher B. Ford, Mary-Jane Lombardo, Barbara McGovern, Lisa Von Moltke, Colleen S. Kraft, Matthew R. Henn, (unknown)	0
2	Body mass index changes after fecal microbiota transplantation for recurrent Clostridioides difficile infection 2025 ·Therapeutic Advances in Gastroenterology ·(unknown), (unknown), Janice Cho, (unknown), Ross Dierkhising, Eric Battaglioli, Purna Kashyap, Darrell S. Pardi, Sahil Khanna	1
3	AGA Clinical Practice Update on Sclerosing Mesenteritis: Commentary 2025 ·Clinical Gastroenterology and Hepatology ·M. Worthington, Jacqueline L. Wolf, Seth D. Crockett, Darrell S. Pardi	0
4	Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care 2024 ·Drugs & Aging ·Ole Haagen Nielsen, Darrell S. Pardi	5
5	Embedding Internal Accountability Into Health Care Institutions for Safe, Effective, and Ethical Implementation of Artificial Intelligence Into Medical Practice: A Mayo Clinic Case Study 2024 ·SHILAP Revista de lepidopterología ·(unknown), David Vidal, David S. McClintock, Mark A. Lifson, Eric E. Williamson, (unknown), (unknown), Melissa C. Lipford, Darrell S. Pardi	5
6	Psychiatric Disorders Among 5,800 Patients With Microscopic Colitis: A Nationwide Population-Based Matched Cohort Study 2024 ·The American Journal of Gastroenterology ·David Bergman, Björn Roelstraete, Jiangwei Sun, Fahim Ebrahimi, Agnieszka Butwicka, Darrell S. Pardi, Jonas F. Ludvigsson	0
7	IMPACT OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS ON BOWEL PREPARATION FOR COLONOSCOPY 2024 ·Gastrointestinal Endoscopy ·(unknown), (unknown), (unknown), (unknown), (unknown), Darrell S. Pardi, Nayantara Coelho‐Prabhu	1
8	CLINICAL OUTCOMES OF INFLAMMATORY BOWEL DISEASE AFTER ORTHOTOPIC HEART TRANSPLANT. 2024 ·Gastroenterology ·Ahmed T. Kurdi, Darrell S. Pardi, Edward V. Loftus, Manreet Kaur, Francis A. Farraye, (unknown)	0
9	Integrated efficacy analysis from phase 3 studies of investigational microbiome therapeutic, SER-109, in recurrent Clostridioides difficile infection 2023 ·SHILAP Revista de lepidopterología ·Matthew Sims, Michael Silverman, Thomas Louie, Elaine Wang, (unknown), Mayur Ramesh, Tatiana Bogdanovich, (unknown), David A. Lombardi, Aslı Memişoğlu, Ananya De, (unknown), Christine Lee, Paul Feuerstadt, Darrell S. Pardi, Colleen Kelly, Peter Daley, Godson Oguchi, Barbara McGovern, Lisa Von Moltke	1
10	Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic Colitis 2022 ·Crohn s & Colitis 360 ·Thomas Fredrick, Guilherme Piovezani Ramos, Manuel B. Braga Neto, Sunanda V. Kane, William A. Faubion, Edward V. Loftus, Darrell S. Pardi, Shabana F. Pasha, Francis A. Farraye, Lizhi Zhang, Laura E. Raffals	4
11	Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center Experience 2021 ·Crohn s & Colitis 360 ·Guilherme Piovezani Ramos, Badr Al‐Bawardy, Manuel B. Braga Neto, Adam C. Bledsoe, Kevin P. Quinn, (unknown), Maria Alice V. Willrich, (unknown), Victor Chedid, Nayantara Coelho‐Prabhu, John B. Kisiel, Konstantinos A. Papadakis, Darrell S. Pardi, Sunanda V. Kane, William J. Tremaine, Laura E. Raffals, David H. Bruining, William A. Faubion, William S. Harmsen, Edward V. Loftus	2
12	Medication use and microscopic colitis: a multicentre retrospective cohort study 2021 ·Alimentary Pharmacology & Therapeutics ·Haley M. Zylberberg, Amrit K. Kamboj, (unknown), (unknown), Sahil Khanna, Darrell S. Pardi, Benjamin Lebwohl	19
13	Development of a Microscopic Colitis Disease Activity Index: a prospective cohort study 2016 ·Gut ·Thomas G. Cotter, Moritz Binder, Edward V. Loftus, (unknown), (unknown), Thomas C. Smyrk, William J. Tremaine, William J. Sandborn, Darrell S. Pardi	26
14	Outcomes With Fidaxomicin Therapy in Clostridium difficile Infection 2016 ·Journal of Clinical Gastroenterology ·Clayton M. Spiceland, Sahil Khanna, Darrell S. Pardi	34
15	Safety and Durability of RBX2660 (Microbiota Suspension) for RecurrentClostridium difficileInfection: Results of the PUNCH CD Study 2015 ·Clinical Infectious Diseases ·Robert Orenstein, (unknown), Erik R. Dubberke, Robert Hardi, Arnab Ray, Kathleen M. Mullane, Darrell S. Pardi, Mayur Ramesh	161
16	Meta‐analysis: serological markers and the risk of acute and chronic pouchitis 2013 ·Alimentary Pharmacology & Therapeutics ·Siddharth Singh, Piyush Kumar Sharma, Edward V. Loftus, Darrell S. Pardi	41
17	Tacrolimus Salvage in Anti–Tumor Necrosis Factor Antibody Treatment-Refractory Crohn’s Disease 2013 ·Inflammatory Bowel Diseases ·Mark E. Gerich, Darrell S. Pardi, David H. Bruining, Patricia P. Kammer, (unknown), (unknown)	10
18	Gastric acid suppression and outcomes from clostridium difficile infection: a population-based study 2011 ·Gut ·Sahil Khanna, Scott Aronson, Patricia P. Kammer, Darrell S. Pardi	1
19	Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial 2008 ·Gastrointestinal Endoscopy ·Craig A. Solem, Edward V. Loftus, Joel G. Fletcher, Todd H. Baron, Christopher J. Gostout, Bret T. Petersen, William J. Tremaine, Laurence J. Egan, William A. Faubion, Kenneth W. Schroeder, Darrell S. Pardi, Karen A. Hanson, (unknown), John M. Barlow, Jeff L. Fidler, James E. Huprich, C. Daniel Johnson, William S. Harmsen, Alan R. Zinsmeister, William J. Sandborn	247
20	Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations. 2007 ·PubMed Central ·Paul Evans, Darrell S. Pardi	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact